Conroy Kevin T. - 13 Nov 2024 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Role
President and CEO, Director
Signature
/s/ Kevin T. Conroy by Mark Busch, attorney-in- fact
Issuer symbol
EXAS
Transactions as of
13 Nov 2024
Net transactions value
+$1,001,325
Form type
4
Filing time
13 Nov 2024, 12:56:28 UTC
Previous filing
24 May 2024
Next filing
29 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXAS Common Stock Purchase $1,001,325 +19,500 +1.8% $51.35 1,074,191 13 Nov 2024 Direct F1, F2
holding EXAS Common Stock 28,084 13 Nov 2024 Held in 401(k) Plan
holding EXAS Common Stock 73,280 13 Nov 2024 Held in Grantor Retained Annuity Trust
holding EXAS Common Stock 72,067 13 Nov 2024 Held in Grantor Retained Annuity Trust
holding EXAS Common Stock 21,730 13 Nov 2024 Held in Grantor Retained Annuity Trust
holding EXAS Common Stock 21,730 13 Nov 2024 Held in Grantor Retained Annuity Trust
holding EXAS Common Stock 21,729 13 Nov 2024 Held in Grantor Retained Annuity Trust
holding EXAS Common Stock 101,500 13 Nov 2024 Held in Grantor Retained Annuity Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Kevin Conroy purchased in the open market 19,500 shares of Exact Sciences Corp. Common Stock at a price per share of $51.35, representing $1,001,325 worth of shares.
F2 In addition to the shares of Common Stock reported on this Form 4, which total 1,414,311 shares, Mr. Conroy also holds, in the aggregate, an additional 683,018 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.